CDC expands testing of international air traveler samples to include flu RSV, and other respiratory viruses

CDC is conducting a new pilot on samples it is collecting as part of its Traveler-based Genomic Surveillance (TGS) program that will provide early detection of flu, RSV, and select other respiratory viruses, in addition to SARS-CoV-2.  The pilot, which will last for several months, will be implemented by Ginkgo Bioworks and XpresCheck. Samples that..

Read more

CDC’s National Institute for Occupational Safety and Health Launches First Federal Campaign for Hospitals to Tackle Healthcare Workers Burnout

Washington, D.C. (October 31, 2023) – The Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH) announced today the launch of Impact Wellbeing. This new campaign provides hospital leaders with evidence-informed resources to improve workplace policies and practices that reduce burnout, normalize help-seeking, and strengthen professional wellbeing. “Even before..

Read more

CDC recommends new vaccine to help protect babies against severe respiratory syncytial virus (RSV) illness after birth

Today, CDC recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborn from severe RSV illness. RSV is the leading cause of hospitalization for U.S. infants. This new vaccine, Pfizer’s bivalent RSVpreF vaccine (trade name Abrysvo TM), has been shown to reduce the risk of RSV hospitalization for babies by 57 percent in the first six..

Read more

CDC announces $262M funding to support National Network for Outbreak Response and Disease Modeling

On September 19, 2022, CDC announced the recipients of 13 funding awards to establish a first-of-its-kind national network, the Outbreak Analytics and Disease Modeling Network (OADMN). The awards, totaling $262.5 million in funding over a five-year period, will support state and local decision-makers in developing and implementing new tools to detect, respond to, and mitigate..

Read more

HHS Launches Bridge Access Program to Ensure Free COVID-19 Vaccination for Uninsured and Underinsured Adults

In April, HHS announced the ‘HHS Bridge Access Program For COVID-19 Vaccines and Treatments Program’(“Program”) to maintain broad access to COVID-19 vaccines for millions of uninsured Americans. This week, the Bridge Access Program officially launches, providing continued free coverage for the estimated 25-30 million adults who would have otherwise lost access to affordable COVID-19 vaccines..

Read more